Literature DB >> 29605572

Decreased ghrelin and des-acyl ghrelin plasma levels in patients affected by pharmacoresistant epilepsy and maintained on the ketogenic diet.

Maddalena Marchiò1, Laura Roli2, Carmela Giordano3, Tommaso Trenti2, Azzurra Guerra4, Giuseppe Biagini5.   

Abstract

BACKGROUND & AIMS: The gastric hormones ghrelin and des-acyl ghrelin have been found to be altered in patients treated with antiepileptic drugs. However, it is unknown if these hormones could be modified by other antiepileptic treatments, such as the ketogenic diet. Especially, a reduction in ghrelin levels could be relevant in view of the growth retardation observed under ketogenic diet treatment. For this reason we aimed to determine the changes in ghrelin and des-acyl ghrelin plasma levels in children affected by refractory epilepsy and treated with the ketogenic diet up to 90 days.
METHODS: Both peptides were measured by immunoassays in plasma obtained from 16 children.
RESULTS: Ghrelin plasma levels were progressively reduced by the ketogenic diet, reaching a minimum corresponding to 42% of basal levels after 90 days of ketogenic diet (P < 0.05, Duncan's test). Des-acyl ghrelin plasma levels were similarly affected, reaching minimal levels at 30 days (65% of basal levels), and maintaining a significant reduction until 90 days after the onset of ketogenic diet (P < 0.01 for both time intervals). No significant changes in growth were observed during the monitored period of ketogenic diet administration.
CONCLUSIONS: Ghrelin and des-acyl ghrelin are downregulated by the ketogenic diet in children affected by refractory epilepsy. Although no significant changes in growth were observed during the short time period of our investigation, the reduction in ghrelin availability may explain the reported growth retardation found in children treated with the ketogenic diet in the long-term.
Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Antiepileptic drugs; Des-acyl ghrelin; Epilepsy; Ghrelin; Ketogenic diet

Mesh:

Substances:

Year:  2018        PMID: 29605572     DOI: 10.1016/j.clnu.2018.03.009

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  8 in total

Review 1.  Emerging treatments for progressive myoclonus epilepsies.

Authors:  Antonella Riva; Alberto Guglielmo; Ganna Balagura; Francesca Marchese; Elisabetta Amadori; Michele Iacomino; Berge Arakel Minassian; Federico Zara; Pasquale Striano
Journal:  Expert Rev Neurother       Date:  2020-03-17       Impact factor: 4.618

2.  Ghrelin Plasma Levels After 1 Year of Ketogenic Diet in Children With Refractory Epilepsy.

Authors:  Maddalena Marchiò; Laura Roli; Chiara Lucchi; Anna Maria Costa; Matteo Borghi; Lorenzo Iughetti; Tommaso Trenti; Azzurra Guerra; Giuseppe Biagini
Journal:  Front Nutr       Date:  2019-07-24

Review 3.  Ketogenic Diets and Exercise Performance.

Authors:  Kristin L Harvey; Lola E Holcomb; Stephen C Kolwicz
Journal:  Nutrients       Date:  2019-09-26       Impact factor: 5.717

4.  Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models.

Authors:  Csilla Ari; Cem Murdun; Craig Goldhagen; Andrew P Koutnik; Sahil R Bharwani; David M Diamond; Mark Kindy; Dominic P D'Agostino; Zsolt Kovacs
Journal:  Nutrients       Date:  2020-08-15       Impact factor: 5.717

5.  Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet.

Authors:  Anna-Maria Costa; Maddalena Marchiò; Giulia Bruni; Silvia Maria Bernabei; Silvia Cavalieri; Marina Bondi; Giuseppe Biagini
Journal:  Nutrients       Date:  2021-04-09       Impact factor: 5.717

6.  Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies.

Authors:  Anna-Maria Costa; Tommaso Lo Barco; Elisabetta Spezia; Valerio Conti; Laura Roli; Lorenza Marini; Sara Minghetti; Elisa Caramaschi; Laura Pietrangelo; Luca Pecoraro; Fabio D'Achille; Paola Accorsi; Tommaso Trenti; Federico Melani; Carla Marini; Renzo Guerrini; Francesca Darra; Patrizia Bergonzini; Giuseppe Biagini
Journal:  J Pers Med       Date:  2022-03-25

Review 7.  Shared Etiology in Autism Spectrum Disorder and Epilepsy with Functional Disability.

Authors:  Aqeela Zahra; YunFu Wang; Qun Wang; Jianping Wu
Journal:  Behav Neurol       Date:  2022-04-27       Impact factor: 3.112

Review 8.  Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy.

Authors:  An Buckinx; Dimitri De Bundel; Ron Kooijman; Ilse Smolders
Journal:  Biomedicines       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.